Market Highlights According to MRFR analysis, Biosimulation Market is expected to register a CAGR of 15.9% during the forecast period of 2019 to 2025 and is likely to be valued at USD 4.4 Billion by 2025.  Biosimulation is a tool used for the prediction of the outcomes of existing clinical trials associated with innovation and new drug development. The growth of the...